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Table 1
Biochemical and microscopic characteristics of ESBL positive bacteria
S. No.
Agar Media Biochemical
test
Microscopic
results
Identiﬁcation
Meth. Red Vog. Pros. Cit. Shape of
bacteria
Gram staining
-ve control MacConkey /
Nutrient
NA NA NA NA NA NA NA
1 MacConkey + + - - Cocci -ve E. coli
2 MacConkey - - + + Small rods -ve K. Pneumoniae
3 Nutrient - - + + Cocci -ve Enterobacter spp.
* Note: Ind= Indole; MR= Methyl Red; VP = Voges Proskauer; cit= citrate; NA=not applicable.
Figure 1. Gel showing (A) 966 bp fragment of bla TEM, (B) 1007 bp fragment of
bla SHV, and (C) 550 bp fragment of bla CTX-M (M = 1.5kb DNA ladder, Bangalore
Genei).
Agra could be screened to know linkage between environmental
sources and clinical cases.
http://dx.doi.org/10.1016/j.ijid.2016.02.663
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Background: The continuum characterization of circulating
RVAgenotypes is essential to understand howvaccine introduction
could impact virus epidemiology. In the present study, an unex-
pected rapid changing pattern of RVA genotypes distribution in
Brazilian population during three followed seasons is described.
Methods & Materials: From January/2012 to December/2014,
a total of 3441 fecal specimens were collected from collaborat-
ing centers across Southern, Southeastern and Midwest Brazil, and
likely to be representative of Brazilian population. All specimens
were screened for RVA using ELISA, and genotyped by RT-PCR. Dif-
ferences in proportions were tested using Chi Squares. A p-value of
less than 0.05 was considered statistically signiﬁcant.
Results: RVA was detected in 19.7% (677/3441). G3P[8]
remained prevalent in 2012 (37.6%, 69/185) and 2013 (40.1%,
74/186) (2=0.107, p=0.743), but declined markedly in 2014
(3.5%, 10/281) (2=71.770, p=0.000). G12P[8] was second high-
est strain in 2012 (22.7%, 42/185), decrease rapidly in 2013 (2.7%,
5/186) (2=26.224, p=0.000) and re-emerged as the predominant
genotype in 2014 (86.6%, 243/281) (2=118.299, p=0.000). From
July/2014, G12P[8] was the single genotype detected in all regions
studied.
Conclusion: The present study raised the hypothesis of a possi-
ble G12 outbreak being in progress. Nationally, the Hospital-based
Information System surveillance data conﬁrmed the long term
decline in gastroenteritis hospitalization observed in Brazil after
RVA vaccine introduction. Nevertheless, the sharp increase in diar-
rhea hospitalization prevalence from 2013 to 2014 observed in
Southern and Southeastern regions is consistentwithwhat appears
to be an outbreak of G12P[8]. Furthermore, in 2014, the FIFA World
Cup was held in Brazil, and the introduction a novel RVA strain was
a real threat, given large numbers of visitors from areas with ongo-
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ing G12P[8] genotype transmission. Moreover, this event occurred
right before the beginning of the RVA seasonality in the country.
Worldwide, the emergence of genotype G12P[8] as an epidemio-
logically important strain could raise new concerns for RVA vaccine
development. However, despite the possible emergence of new
strains, vaccination has been shown to reduce the disease inci-
dence of RVA infection and remain below pre-vaccination levels.
Continued surveillance is needed to verify the effectiveness of the
RotarixTM vaccine in Brazil together with potential emergence of
unusual genotypes.
http://dx.doi.org/10.1016/j.ijid.2016.02.664
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Background: Human enteroviruses are classiﬁed into four
species (A, B, C and D) and include over 100 serotypes. Since 1997,
Enterovirus 71(EV71) usually causes self-limited infections with
non-speciﬁc symptoms and manifests hand-food-month disease
(HFMD) or herpangina in children. EV71 have caused severe life-
threatening outbreaks in young children in Asian. EV71 circulation
among Vietnamese children was ﬁrst documented in 2005.
Methods & Materials: In 2011, there is a big outbreak of EV71
in Vietnam with more than 5,000 inpatients in Children Hospital
No.1 (CH1), and 32 fetal cases. National Health Research Institutes
cooperates with CH1 to establish hospital-based surveillance of
enterovirus in HCM City in 2011. Children <10 years of age who
develop HFMD and were admitted to HCM CH1 were collected
throat swabs and sera. Throat swabs were used for virus isolation
and Sera were used to measure neutralizing antibody against EV71
in Taiwan NHRI.
Results: Enterovirus isolate rate with HFMD-related inpatients
including 38.9% (21/54) in 2011, 19.3% (79/409) in 2012, 42.0%
(173/412) in 2013 and 12% (12/100) on June, 2014. Among them,
EV71 positive rate from 2011 to June, 2014 were 29.6%, 6.8%, 16.0%
and 5%, respectively. The age-speciﬁc seropositive rates increase
from 15.2% at <0.5 years of age to 17.2, 24.0, 29.4, 58.6, 62.3, 66.1,
77.6% at 0.5-0.9, 1-1.9, 2-2.9, 3-3.9, 4-4.9, 5-5.9 and 6-6.9 years of
age, respectively.
Conclusion: The predominant genotype shifted fromC4 in 2011
to B5 in 2013. Risk of EV71 infections in Vietnam increased after 6
months of age. Vietnamese children in HCM City acquired EV71
infections at early age and vaccine development in Vietnam should
target young children.
http://dx.doi.org/10.1016/j.ijid.2016.02.665
